Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editor's pick

17-09-2019 | Rheumatoid arthritis | Highlight | News

Global RA burden ‘significant, yet under-recognized’

Almost 20 million people worldwide were living with rheumatoid arthritis in 2017, with over a million new cases diagnosed each year, according to estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study.

13-09-2019 | Axial spondyloarthritis | Feature | Article

A closer look at the US guidelines for managing axSpA

Michael Ward talks about what’s new in the updated US guidelines for the management of ankylosing spondylitis and nonradiographic axial spondyloarthritis.

10-09-2019 | Gout | Editorial | Article

The 2018 updated EULAR recommendations for the diagnosis of gout: What's new, what's changed, and what's gone?

Editorial Board member Fernando Pérez-Ruiz summarizes the key changes in the 2018 updated EULAR recommendations for the diagnosis of gout.

Latest from across the site

20-09-2019 | Total hip replacement | News

Multiple modifiable risk factors impact post hip replacement dislocation risk

Dislocation risk following total hip replacement is declining with time and is associated with a number of surgical, hospital, and patient-related factors that are generally modifiable, UK researchers report.

19-09-2019 | Rheumatoid arthritis | News

IL-1 inhibition may benefit for people with RA, type 2 diabetes

Treatment with the interleukin-1 inhibitor anakinra improves both glycemic and inflammatory endpoints among patients with rheumatoid arthritis and type 2 diabetes, suggest findings from the TRACK trial.

18-09-2019 | Psoriatic arthritis | News

Ustekinumab efficacious in TNF-inhibitor naïve PsA patients

Ustekinumab elicits a greater clinical response versus placebo in patients with psoriatic arthritis naïve to tumor necrosis factor inhibitors, regardless of prior conventional synthetic DMARD or methotrexate exposure, PSUMMIT 1 and PSUMMIT 2 study data show.

17-09-2019 | Rheumatoid arthritis | Highlight | News

Global RA burden ‘significant, yet under-recognized’

Almost 20 million people worldwide were living with rheumatoid arthritis in 2017, with over a million new cases diagnosed each year, according to estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study.

16-09-2019 | Psoriatic arthritis | News

Early tight control strategy may not have long-term benefits for PsA patients

Follow-up results from the TICOPA study suggest no long-term clinical advantage of an early treat-to-target strategy for patients with psoriatic arthritis.

13-09-2019 | Axial spondyloarthritis | Feature | Article

A closer look at the US guidelines for managing axSpA

Michael Ward talks about what’s new in the updated US guidelines for the management of ankylosing spondylitis and nonradiographic axial spondyloarthritis.

Latest from us on Twitter

Trending this week

Meet our Editorial Board

New Content Item Meet our Advisory Board

Image Credits